Kovacs, Boldizsar
Mayinger, Michael
Ehrbar, Stefanie
Fesslmeier, Debra
Ahmadsei, Maiwand
Sazgary, Lorraine
Manka, Robert
Alkadhi, Hatem
Ruschitzka, Frank
Duru, Firat
Papachristofilou, Alexandros
Sticherling, Christian
Blamek, Slawomir
Gołba, Krzysztof S.
Guckenberger, Matthias
Saguner, Ardan M.
Andratschke, Nicolaus
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P500PM_203194)
Horizon 2020 (No 945119)
Article History
Received: 26 June 2023
Accepted: 8 October 2023
First Online: 8 November 2023
Declarations
:
: The study has been approved by the Cantonal Ethics Committee of Zurich, Switzerland (BASEC 2022 − 00262). This study will be conducted in compliance with the protocol, the current version of the Declaration of Helsinki, ICH-GCP, as well as all national legal and regulatory requirements. Written informed consent will be obtained from all participants.
: Not applicable.
: N.A. has received personal fees from Debiopharm, personal fees from Astrazeneca, grants, personal fees, and non-financial support from ViewRay, and grants from Brainlab. MM: nothing to declare. AMS received educational grants through his institution from Abbott, Bayer Healthcare, Biosense Webster, Biotronik, Boston Scientific, BMS/Pfizer, and Medtronic; and speaker /advisory board /consulting fees from Bayer Healthcare, Biotronik, Daiichi-Sankyo, Medtronic, Novartis, Pfizer and Stride Bio Inc.AP: received honoraria through his institution from Astellas Pharma, Janssen, Sanofi, Bayer, and speaker/advisory board/ consulting fees from Merck Serono, Sanofi, Janssen. BK is supported by the Swiss National Science Foundation Mobility Fellowship (P500PM_203194) and a research grant by the Swiss Rhythmology Foundation. RM has received speaker /advisory board /consulting fees from Bayer Healthcare and Siemens. The other authors have nothing to declare.